These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25543199)

  • 21. A new model using number of needles and androgen deprivation to predict chronic urinary toxicity for high or low dose rate prostate brachytherapy.
    Vargas C; Ghilezan M; Hollander M; Gustafson G; Korman H; Gonzalez J; Martinez A
    J Urol; 2005 Sep; 174(3):882-7. PubMed ID: 16093980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prostate HDR brachytherapy catheter displacement between planning and treatment delivery.
    Whitaker M; Hruby G; Lovett A; Patanjali N
    Radiother Oncol; 2011 Dec; 101(3):490-4. PubMed ID: 21889221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dosimetric impact of prostate volume change between CT-based HDR brachytherapy fractions.
    Kim Y; Hsu IC; Lessard E; Vujic J; Pouliot J
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):1208-16. PubMed ID: 15234057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Automatic shape-based level set segmentation for needle tracking in 3-D TRUS-guided prostate brachytherapy.
    Yan P; Cheeseborough JC; Chao KS
    Ultrasound Med Biol; 2012 Sep; 38(9):1626-36. PubMed ID: 22763006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multi-needle Localization with Attention U-Net in US-guided HDR Prostate Brachytherapy.
    Zhang Y; Lei Y; Qiu RLJ; Wang T; Wang H; Jani AB; Curran WJ; Patel P; Liu T; Yang X
    Med Phys; 2020 Jul; 47(7):2735-2745. PubMed ID: 32155666
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An integrated system for clinical treatment verification of HDR prostate brachytherapy combining source tracking with pretreatment imaging.
    Smith RL; Hanlon M; Panettieri V; Millar JL; Matheson B; Haworth A; Franich RD
    Brachytherapy; 2018; 17(1):111-121. PubMed ID: 28958735
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dosimetric impact of interfraction catheter movement in high-dose rate prostate brachytherapy.
    Foster W; Cunha JA; Hsu IC; Weinberg V; Krishnamurthy D; Pouliot J
    Int J Radiat Oncol Biol Phys; 2011 May; 80(1):85-90. PubMed ID: 20605353
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Real-time in vivo dosimetry in high dose rate prostate brachytherapy.
    Mason J; Mamo A; Al-Qaisieh B; Henry AM; Bownes P
    Radiother Oncol; 2016 Aug; 120(2):333-8. PubMed ID: 27236248
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.
    Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of the No Action Level (NAL) protocol to correct for prostate motion based on electronic portal imaging of implanted markers.
    de Boer HC; van Os MJ; Jansen PP; Heijmen BJ
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):969-83. PubMed ID: 15752876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Needle migration and dosimetric impact in high-dose-rate brachytherapy for prostate cancer evaluated by repeated MRI.
    Buus S; Lizondo M; Hokland S; Rylander S; Pedersen EM; Tanderup K; Bentzen L
    Brachytherapy; 2018; 17(1):50-58. PubMed ID: 28935450
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New interstitial HDR brachytherapy technique for prostate cancer: CT based 3D planning after transrectal implantation.
    Martin T; Kolotas C; Dannenberg T; Strassmann G; Vogt HG; Heyd R; Rogge B; Baltas D; Kurek R; Tunn U; Zamboglou N
    Radiother Oncol; 1999 Sep; 52(3):257-60. PubMed ID: 10580873
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo thermoluminescence dosimetry dose verification of transperineal 192Ir high-dose-rate brachytherapy using CT-based planning for the treatment of prostate cancer.
    Anagnostopoulos G; Baltas D; Geretschlaeger A; Martin T; Papagiannis P; Tselis N; Zamboglou N
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(4):1183-91. PubMed ID: 14575851
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conformal prostate brachytherapy: initial experience of a phase I/II dose-escalating trial.
    Martinez A; Gonzalez J; Stromberg J; Edmundson G; Plunkett M; Gustafson G; Brown D; Yan D; Vicini F; Brabbins D
    Int J Radiat Oncol Biol Phys; 1995 Dec; 33(5):1019-27. PubMed ID: 7493828
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intraoperative optimization of needle placement and dwell times for conformal prostate brachytherapy.
    Edmundson GK; Yan D; Martinez AA
    Int J Radiat Oncol Biol Phys; 1995 Dec; 33(5):1257-63. PubMed ID: 7493850
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of oedema on implant geometry and dosimetry for temporary high dose rate brachytherapy of the prostate.
    Kiffer JD; Schumer WA; Mantle CA; McKenzie BJ; Feigen M; Quong GG; Waterman FM
    Australas Radiol; 2003 Jun; 47(2):172-6. PubMed ID: 12780447
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate gland motion and deformation caused by needle placement during brachytherapy.
    Stone NN; Roy J; Hong S; Lo YC; Stock RG
    Brachytherapy; 2002; 1(3):154-60. PubMed ID: 15090279
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 3-D conformal HDR brachytherapy as monotherapy for localized prostate cancer. A pilot study.
    Martin T; Baltas D; Kurek R; Röddiger S; Kontova M; Anagnostopoulos G; Dannenberg T; Buhleier T; Skazikis G; Tunn U; Zamboglou N
    Strahlenther Onkol; 2004 Apr; 180(4):225-32. PubMed ID: 15057433
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Seed displacements after permanent brachytherapy for prostate cancer in dependence on the prostate level.
    Pinkawa M; Gagel B; Asadpour B; Piroth MD; Klotz J; Borchers H; Jakse G; Eble MJ
    Strahlenther Onkol; 2008 Oct; 184(10):520-5. PubMed ID: 19016041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Three-dimensional transrectal ultrasound guided high-dose-rate prostate brachytherapy: A comparison of needle segmentation accuracy with two-dimensional image guidance.
    Hrinivich WT; Hoover DA; Surry K; Edirisinghe C; Montreuil J; D'Souza D; Fenster A; Wong E
    Brachytherapy; 2016; 15(2):231-9. PubMed ID: 26832673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.